13-113495697-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017905.6(TMCO3):c.116G>A(p.Arg39Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000342 in 1,460,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_017905.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMCO3 | NM_017905.6 | c.116G>A | p.Arg39Gln | missense_variant | 2/13 | ENST00000434316.7 | NP_060375.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMCO3 | ENST00000434316.7 | c.116G>A | p.Arg39Gln | missense_variant | 2/13 | 1 | NM_017905.6 | ENSP00000389399.2 | ||
TMCO3 | ENST00000375391.5 | c.116G>A | p.Arg39Gln | missense_variant | 2/8 | 1 | ENSP00000364540.1 | |||
TMCO3 | ENST00000474393.5 | c.116G>A | p.Arg39Gln | missense_variant | 2/9 | 2 | ENSP00000484053.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000479 AC: 12AN: 250502Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135566
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1460494Hom.: 0 Cov.: 32 AF XY: 0.0000386 AC XY: 28AN XY: 726282
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | The c.116G>A (p.R39Q) alteration is located in exon 2 (coding exon 1) of the TMCO3 gene. This alteration results from a G to A substitution at nucleotide position 116, causing the arginine (R) at amino acid position 39 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at